Published in Clin Chem on January 01, 1999
Deamidation of human proteins. Proc Natl Acad Sci U S A (2001) 1.53
Prediction of protein deamidation rates from primary and three-dimensional structure. Proc Natl Acad Sci U S A (2001) 1.36
Molecular basis of a novel adaptation to hypoxic-hypercapnia in a strictly fossorial mole. BMC Evol Biol (2010) 0.84
Adult and fetal haemoglobin J-Sardegna [alpha50(CE8)His-->Asp]: functional and molecular modelling studies. Biochem J (2000) 0.83
Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A (1994) 6.72
Juxtaposed regions of extensive and minimal linkage disequilibrium in human Xq25 and Xq28. Nat Genet (2000) 5.65
Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet (1996) 4.62
Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med (1993) 4.36
The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet (2001) 4.15
Polymorphism of DNA sequence in the beta-globin gene region. Application to prenatal diagnosis of beta 0 thalassemia in Sardinia. N Engl J Med (1980) 3.72
A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation (2007) 2.93
Prenatal diagnosis of beta-thalassemia. Detection of a single nucleotide mutation in DNA. N Engl J Med (1983) 2.78
beta zero thalassemia in Sardinia is caused by a nonsense mutation. J Clin Invest (1981) 2.30
ICSH recommendations for the measurement of haemoglobin A2. Int J Lab Hematol (2011) 2.23
Relationship between neonatal screening results by HPLC and the number of α-thalassaemia gene mutations; consequences for the cut-off value. J Med Screen (2011) 2.05
Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet (1994) 2.01
Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson (2006) 1.97
An atlas-based method to compensate for brain shift: preliminary results. Med Image Anal (2007) 1.91
Effect of phosphorus availability on basal root shallowness in common bean. Plant Soil (2001) 1.89
Is heartworm disease really spreading in Europe? Vet Parasitol (2005) 1.74
Mitochondrial DNA polymorphisms in Italy. I. Population data from Sardinia and Rome. Ann Hum Genet (1986) 1.73
Healing of broken human chromosomes by the addition of telomeric repeats. Am J Hum Genet (1994) 1.69
The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet (1998) 1.67
Heterozygous beta-thalassemia: relationship between the hematological phenotype and the type of beta-thalassemia mutation. Am J Hematol (1992) 1.62
Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol (1993) 1.52
Detection of anti-lipoarabinomannan antibodies for the diagnosis of active tuberculosis. Int J Tuberc Lung Dis (1998) 1.50
Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy. J Neurol Neurosurg Psychiatry (1993) 1.49
Interaction between the glucose-6-phosphate dehydrogenase deficiency and thalassaemia genes at phenotype level. Br J Haematol (1980) 1.49
Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in Sardinia. Am J Hum Genet (1981) 1.47
Initiation codon mutation as a cause of alpha thalassemia. J Biol Chem (1984) 1.45
Hyperbilirubinemia, glucose-6-phosphate-dehydrogenase deficiency and Gilbert's syndrome. Eur J Pediatr (1999) 1.45
A specific cystic fibrosis mutation (T3381) associated with the phenotype of isolated hypotonic dehydration. J Pediatr (1995) 1.43
Relationship between genotype and phenotype. Thalassemia intermedia. Ann N Y Acad Sci (1998) 1.34
Safety profile of the oral iron chelator deferiprone: a multicentre study. Br J Haematol (2000) 1.32
hMAF, a small human transcription factor that heterodimerizes specifically with Nrf1 and Nrf2. J Biol Chem (1997) 1.31
A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet (1998) 1.30
Molecular characterization of wilson disease in the Sardinian population--evidence of a founder effect. Hum Mutat (1999) 1.27
Control of beta-thalassaemia by carrier screening, genetic counselling and prenatal diagnosis: the Sardinian experience. Ciba Found Symp (1996) 1.27
Wolbachia surface protein (WSP) inhibits apoptosis in human neutrophils. Parasite Immunol (2007) 1.25
Hb F production in stressed erythropoiesis: observations and kinetic models. Ann N Y Acad Sci (1985) 1.20
The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci. Hum Immunol (1995) 1.18
A gene dosage effect of the DQA1*0501/DQB1*0201 allelic combination influences the clinical heterogeneity of celiac disease. Hum Immunol (1994) 1.18
Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome. Dev Dyn (1998) 1.17
Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea. N Engl J Med (1985) 1.16
Thalassaemia types and their incidence in Sardinia. J Med Genet (1978) 1.16
Molecular diagnosis and carrier screening for beta thalassemia. JAMA (1997) 1.16
Molecular basis of hemoglobin-H disease in the Mediterranean population. Blood (1979) 1.14
Phenotypic effect of heterozygous alpha and beta 0-thalassemia interaction. Blood (1983) 1.14
Genotype-phenotype correlations in beta-thalassemias. Blood Rev (1994) 1.11
Combined ivermectin and doxycycline treatment has microfilaricidal and adulticidal activity against Dirofilaria immitis in experimentally infected dogs. Int J Parasitol (2008) 1.11
Beta 0 thalassemia trait in Sardinia. Hemoglobin (1979) 1.09
The prevention of thalassemia in Sardinia. Clin Genet (1989) 1.09
The p12f2/TaqI Y-specific polymorphism in three groups of Italians and in a sample of Senegalese. Gene Geogr (1987) 1.09
Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study. Nutr Metab Cardiovasc Dis (2009) 1.08
Multiple mutations produce delta beta 0 thalassemia in Sardinia. Science (1984) 1.08
Alpha-thalassemia carrier identification by DNA analysis in the screening for thalassemia. Am J Hematol (1998) 1.08
Clinical and molecular analysis of haemoglobin H disease in Sardinia: haematological, obstetric and cardiac aspects in patients with different genotypes. Br J Haematol (2006) 1.08
Color Doppler ultrasound and prenatal diagnosis of cleft palate. J Clin Ultrasound (1995) 1.07
Elevation of serum creatine kinase as the only manifestation of an intragenic deletion of the dystrophin gene in three unrelated families. Eur J Paediatr Neurol (1998) 1.06
Molecular characterization of beta-thalassemia in the Sardinian population. Am J Hum Genet (1992) 1.06
The osmotic response of large unilamellar vesicles studied by quasielastic light scattering. Biochim Biophys Acta (1986) 1.06
Highly sensitive multiplex PCR for simultaneous detection and discrimination of Dirofilaria immitis and Dirofilaria repens in canine peripheral blood. Vet Parasitol (2010) 1.05
The prenatal diagnosis of thalassaemia. Br J Haematol (1986) 1.04
The interaction of alpha thalassaemia with heterozygous beta thalassaemia. Br J Haematol (1982) 1.04
Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis. Br J Haematol (1999) 1.04
Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major. Br J Haematol (1995) 1.04
Further delineation of the molecular pathology of Wilson disease in the Mediterranean population. Hum Mutat (1998) 1.03
Auditory involvement in thalassemia major. Acta Haematol (1979) 1.02
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. Prostate Cancer Prostatic Dis (2008) 1.02
Molecular comparison of delta beta-thalassemia and hereditary persistence of fetal hemoglobin DNAs: evidence of a regulatory area? Proc Natl Acad Sci U S A (1982) 1.02
Hemoglobin A2 in iron deficient beta-thalassemia heterozygotes. Hemoglobin (1981) 1.02
Beta-thalassemia mutations in the Portuguese population. Hum Genet (1988) 1.02
Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease. Br J Cancer (2005) 1.01
Cholelithiasis and Gilbert's syndrome in homozygous beta-thalassaemia. Br J Haematol (2001) 1.00
Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. Endocr Relat Cancer (2005) 1.00
Wolbachia and its influence on the pathology and immunology of Dirofilaria immitis infection. Vet Parasitol (2008) 1.00
Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta-thalassemia in a non-beta-thalassemia chromosome. Blood (1990) 0.99
The role of haemoglobin A(2) testing in the diagnosis of thalassaemias and related haemoglobinopathies. J Clin Pathol (2009) 0.99
Molecular characterization of beta-thalassemia intermedia in patients of Italian descent and identification of three novel beta-thalassemia mutations. Blood (1991) 0.99
A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo. Oncogene (2012) 0.99
Agenesis of the corpus callosum, infantile spasms, spastic quadriplegia, microcephaly and severe mental retardation in three siblings. Clin Genet (1977) 0.98